NEUROCRINE BIOSCIENCES INC Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Neurocrine Biosciences Inc quarterly/annual Depreciation history and growth rate from 2010 to 2023.
  • Neurocrine Biosciences Inc Depreciation for the quarter ending March 31, 2024 was $5.3M, a 29.3% increase year-over-year.
  • Neurocrine Biosciences Inc annual Depreciation for 2023 was $17.8M, a 17.9% increase from 2022.
  • Neurocrine Biosciences Inc annual Depreciation for 2022 was $15.1M, a 38.5% increase from 2021.
  • Neurocrine Biosciences Inc annual Depreciation for 2021 was $10.9M, a 26.7% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.8M +$2.7M +17.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-09
2022 $15.1M +$4.2M +38.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-09
2021 $10.9M +$2.3M +26.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 $8.6M +$1.2M +16.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $7.4M +$3.4M +85% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $4M +$1.6M +66.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 $2.4M +$900K +60% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 $1.5M +$500K +50% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2015 $1M +$200K +25% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 $800K +$100K +14.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $700K $0 0% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 $700K $0 0% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-09
2011 $700K -$700K -50% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 $1.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.